Soleno Therapeutics (SLNO) Cash & Equivalents Growth (5y) (2018 - 2026)
Soleno Therapeutics (SLNO) Cash & Equivalents Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.16% |
| Dec 31, 2025 | 7.33% |
| Sep 30, 2025 | 34.46% |
| Jun 30, 2025 | 4.13% |
| Mar 31, 2025 | 40.10% |
| Dec 31, 2024 | 33.50% |
| Sep 30, 2024 | 33.95% |
| Jun 30, 2024 | 29.75% |
| Mar 31, 2024 | 17.14% |
| Dec 31, 2023 | 49.01% |
| Sep 30, 2023 | 38.62% |
| Jun 30, 2023 | 9.03% |
| Mar 31, 2023 | 195.61% |
| Dec 31, 2022 | 234.25% |
| Sep 30, 2022 | 255.06% |
| Jun 30, 2022 | 269.48% |
| Mar 31, 2022 | 22.42% |
| Dec 31, 2021 | 260.48% |
| Sep 30, 2021 | 39.09% |
| Jun 30, 2021 | 68.11% |